Experimental evidence indicating that VANGL2 regulates cytoskeletal architecture of maturing podocytes has therefore raised interest in the potential functions of this protein, or other PCP proteins, in podocyte pathology and glomerular disease. Here, VANGL2 is linked to glomerular disorder.